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Abstract
Background: Several studies suggest a decrease in sperm quality in men in the last decades. Therefore, the aim
of this work was to assess the influence of male factors (sperm quality and paternal age) on the outcomes of
conventional in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI).
Methods: This retrospective study included all couples who underwent IVF or ICSI at Montpellier University Hospital,
France, between 1 January 2010 and 31 December 2015. Exclusion criteria were cycles using surgically retrieved sperm
or frozen sperm, with pre-implantation genetic diagnosis or using frozen oocytes. The primary outcomes were
the blastulation rate (number of blastocysts obtained at day 5 or day 6/number of embryos in prolonged culture at
day 3) and the clinical pregnancy rate. The secondary outcomes were the fertilization and early miscarriage rates.
Results: In total, 859 IVF and 1632 ICSI cycles were included in this study. The fertilization rate after ICSI was affected by
oligospermia. Moreover, in ICSI, severe oligospermia (lower than 0.2 million/ml) led to a reduction of the blastulation
rate. Reduced rapid progressive motility affected particularly IVF, with a decrease of the fertilization rate and number of
embryos at day 2 when progressive motility was lower than 32%.
Paternal age also had a negative effect. Although it was difficult to eliminate the bias linked to the woman’s age,
pregnancy rate was reduced in IVF and ICSI when the father was older than 51 and the mother older than 37 years.
Conclusions: These results allow adjusting our strategies of fertilization technique and embryo transfer. In the case of
severe oligospermia, transfer should be carried out at the cleaved embryo stage (day 2–3) due to the very low
blastulation rate. When the man is older than 51 years, couples should be aware of the reduced success rate,
especially if the woman is older than 37 years. Finally, promising research avenues should be explored, such as
the quantification of free sperm DNA, to optimize the selection of male gametes.
Keywords: Sperm quality; Sperm concentration, Progressive motility, Paternal age, Blastulation rate, Rate of
clinical pregnancy
Résumé
Contexte: De nombreuses données suggèrent une altération des paramètres spermatiques ces dernières décennies.
Le but de ce travail est d’évaluer l’impact de facteurs masculins tels la qualité du sperme et l’âge paternel sur les
résultats en fécondation in vitro classique (FIVc) et en fécondation in vitro avec injection intra-cytoplasmique de
spermatozoïde (ICSI).
(Continued on next page)
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Matériels et méthodes: L’étude a porté sur l’ensemble des couples ayant fait l’objet d’une tentative de FIVc ou
d’ICSI entre le 1er janvier 2010 et le 31 décembre 2014 au CHU de Montpellier.
Les critères d’exclusion ont été les tentatives avec utilisation de spermatozoïdes prélevés chirurgicalement ou de
sperme congelé, les cycles avec diagnostic pré-implantatoire et les cycles avec ovocytes congelés.
Au total, 859 ponctions de FIVc et 1632 ponctions d’ICSI ont été incluses dans l’étude.
Résultats: En ICSI, le taux de fécondation est affecté par l’oligospermie. Par ailleurs, une oligospermie extrême
(inférieure à 0,2 M/ml) entraîne une diminution du taux de blastulation.
La mobilité progressive avant préparation a plus d’impact en FIVc, où les taux de fécondation et le nombre
d’embryons obtenus à J2 vont être plus bas lorsque la mobilité progressive est inférieure à 32%.
Même s’il est difficile d’éliminer le biais lié à l’âge de la partenaire, il semblerait qu’il y ait une diminution du taux
de grossesse en FIVc et en ICSI à partir de 51 ans chez l’homme avec une partenaire âgée de plus de 37 ans.
Conclusion: Ces résultats permettront essentiellement d’ajuster nos stratégies de choix de technique de mise en
fécondation et de transfert.
Pour les oligospermies extrêmes, il semble préférable de proposer un transfert précoce au stade embryon clivé
(J2 - J3) car le taux de blastulation est très réduit dans ce cas.
Lorsque l’homme est âgé, il faudra également informer le couple de la diminution des taux de réussite, d’autant
plus si sa partenaire a plus de 37 ans.
Enfin, différentes pistes prometteuses de recherche sont encore à explorer, comme le dosage de l’ADN libre
spermatique afin d’optimiser la sélection des gamètes masculins et ainsi améliorer les résultats en AMP.
Mots clés: Qualité du sperme, Concentration spermatique, Mobilité progressive- age de l’homme- taux de
blastulation, Taux de grossesses cliniques
Background
In France, 1 in 7 couples consult at some point for fertility
problems [1]. In about 15% of couples, the infertility prob-
lem cannot be explained and in 30%, the origin is paternal
[2]. Male infertility is diagnosed, among others, on the
basis of quantitative or qualitative sperm anomalies visual-
ized by semen analysis. The last guidelines by the World
Health Organization (WHO) show a global decrease of the
different sperm parameters compared with the previous
edition of 1999 [3]. Concomitantly, several studies sug-
gest a trend towards a reduced sperm quality in the last
years [4].
Assisted reproduction technology (ART) is a therapeutic
solution that allows circumventing human infertility
through the use of a range of methods, including conven-
tional in vitro fertilization (IVF; the combination of one
oocyte with sperm outside the woman’s body) and intracy-
toplasmic sperm injection (ICSI; a single sperm is injected
directly into the egg). The choice is usually based on the
sperm parameters. Indeed, poor sperm motility and struc-
ture might interfere with fertilization (i.e., crossing the
zona pellucida and fusion with the oocyte cytoplasm). The
last European Society of Human Reproduction and Em-
bryology (ESHRE) report shows that the ratio of IVF to
ICSI has been inverted in the last two decades. Currently,
almost 70% of fertilization attempts are done by ICSI [5].
However, the two techniques result in equivalent delivery
rates: 29.1% (IVF) and 27.9% (ICSI), according to the last
ESHRE report, and 19.2 and 19.3%, respectively, according
to the most recent Agence de la Biomédecine report [6].
Male gametes contribute to 50% of the embryo genome.
However, while maternal age and the reduction of ovarian
reserve are recognized negative prognostic factors for
ART [7], the paternal contribution is less well described in
the literature.
The aim of this work was to assess the influence of pa-
ternal age and sperm quality at ovum pick up on IVF and
ICSI outcomes (fertilization rate, early embryo develop-




This retrospective study concerned all couples who
underwent IVF or ICSI in our ART centre. In total, 859
IVF and 1632 ICSI cycles were carried out between 1
January 2010 and 31 December 2014. Exclusion criteria
were ART cycles using surgically retrieved or frozen
sperm, or cycles with pre-implantation genetic diagnosis
or using frozen oocytes.
Sperm preparation
Semen samples were collected by masturbation the day
of ovum pick up. Sperm selection for IVF and ICSI treat-
ment was performed by discontinuous PureSperm
(Nidacon, Göteborg, Sweden) gradient. Semen samples
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were layered upon a 40/60/80/90% PureSperm density
gradient and centrifuged at 300 g for 15min. This pro-
cedure was followed by a resuspension in 1mL of sperm
culture medium (PureSperm wash, Nidacon, Gothemberg,
Sweden) and a second centrifugation at 300 g for 15 min.
Fertilization technique
The fertilization technique (IVF or ICSI) was chosen
during the consultation with the clinical biologist in
function of the semen analysis results (WHO 2010
guidelines, [8]).
At ovum pick up, a new semen analysis was systematic-
ally performed according to the WHO recommendations.
On the basis of its results, the fertilization technique could
still be changed. As the morphology analysis was not
repeated on that day, the percentage of atypical forms
was not included in our criteria of confirmation or
modification of the fertilization technique. At least 10%
of spermatozoa needed to show rapid progressive motility
(formerly, type a motility) before preparation for IVF.
After sperm preparation, the volume needed to obtain
about 5,000 spermatozoa with normal rapid progressive
motility was calculated by considering arbitrarily 50% of
teratozoospermia in all samples. This volume was then
put in contact, using a micropipette, with the oocyte col-
lected by punction (individual culture in micro-drops). If
less than 10% of spermatozoa showed rapid progressive
motility, or if a volume higher than 5 μL was needed for
each oocyte, IVF was replaced by ICSI.
ICSI could also be directly proposed to couples without
male factor in the case of previous low fertilization rate
(<30%) or unexplained failure by IVF (after three attempts
without pregnancy). During the ICSI procedure, MII
oocytes were fixed by a holding pipette and injected
with the polar body at 6 or 12 o’clock position.
Embryo transfer
The embryo transfer strategy used in this study has been
previously described [9]. It takes into account the mater-
nal age, her antecedents, the number of previous at-
tempts and the score of the obtained embryos. Embryo
selection for transfer was made on the morning of the
day 3. One or two embryos were chosen according to
their morphology grade. All embryos were evaluated
daily with an inverted phase-contrast microscope. They
were graded according a simple morphological classifica-
tion including cell number in relation to the time of
development, percentage of cytoplasmic fragmentation
and cell symmetry [10]. Four groups were distinguished:
excellent (grade 1), good (grade 2), poor (grade 3) and
very poor quality embryo (grade 4). When the woman
was younger than 36 years, at her first attempt, without
major male factor and with at least three high-score em-
bryos at day 3 (grade one or two), one single embryo
was transferred at day 5 post-fertilization. In the other
cases, one or two embryos were transferred at day 3 and
the other embryos were further cultured and then frozen.
Only embryos showing development arrest between day 2
and 3 or major cell division defects (<4 cells at day 3) were
not further cultured.
During the first three days of development, embryos
were cultured individually in 30 μL drops of G1.5TM
PLUS (Vitrolife, Göteborg, Sweden) and then they were
transferred in a reduced volume of 10 μL of G2.5TM
PLUS (Vitrolife, Göteborg, Sweden).
Embryo cryopreservation
At day 5 or 6, blastocysts of adequate quality, according to
the classification by Gardner and Schoolcraft [11], were
cryopreserved. The freezing criteria were: grade three or
higher blastocysts associated with trophectoderm cells of
grade A or B.
Outcomes
The primary outcomes were: blastulation rate (number
of blastocysts obtained at day 5 or day 6/number of
embryos in prolonged culture at day 3) and clinical preg-
nancy rate (beta hCG >1000UI/L and/or heart activity
visualized by ultrasonography). The secondary outcomes
were the fertilization and early miscarriage rates.
Data analysis
Results were analysed separately in function of the used
fertilization technique (IVF or ICSI). For each technique,
cycles were divided in sub-groups on the basis of the
sperm concentration before preparation (<0.2, from 0.2
to 5, from 5 to 15 and >15 million/ml), rapid progressive
motility before preparation (<32 and >32%) and pater-
nal age (from 20 to 29, from 30 to 39, from 40 to 50
and >51 years).
For each sub-group, the mean maternal age, mean
number of oocytes used for fertilization, fertilization
rate, mean number of embryos at day 2 and 3, mean
number of embryos in prolonged culture, mean number
of total blastocysts, mean number of useful blastocysts
(i.e., transferred or cryopreserved blastocysts), mean num-
ber of transferred blastocysts, rate of clinical pregnancy
(beta hCG >1000UI/L and/or heart activity visualized by
ultrasonography) and rate of early miscarriage were
reported.
Unfortunately, some data are missing in our software
program, explaining why the total numbers of cycles is
different between each table.
Statistical analysis
All study data were collected using Microsoft Excel, ver-
sion 2007. Results were expressed as the mean ± standard
deviation (SD) or as percentages. Data were compared
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with the chi-square test and p <0.05 was considered statis-
tically significant. Mean values were compared using the
Kruskal-Wallis test.
Results
Sperm quality, paternal age and IVF results
None of the studied parameters did significantly vary in
function of the sperm concentration, although the clinical
pregnancy rate was slightly lower in the < 15 M/ml group
(28.9 vs 38%). (Table 1).
Reduced sperm motility (less than 32% of rapidly pro-
gressing spermatozoa) affected the fertilization rate (47.98
vs 67.05% in samples with >32% rapidly progressing
spermatozoa; p <0.0001) and the mean number of em-
bryos obtained at day 2 (5.18 vs 6.82; p = 0.03). The mean
number of embryos obtained at day 3 also was slightly
reduced (p almost significant). Conversely, the blastocyst
formation, clinical pregnancy and early miscarriage rates
were not affected by reduced sperm motility (Table 2).
Moreover, in the paternal age group >50 years, several
values were decreased. As the woman’s mean age was
very similar (about 37 years) in the paternal age groups
40–50 and >51 years, an independent effect of the paternal
age after the age of 50 could be hypothesized. Specifically,
fertilization rate, mean number of embryos at day 2 and 3,
mean number of embryos for prolonged culture and mean
number of obtained blastocysts were significantly reduced
in the age group >51 years compared with the other age
groups. The rate of clinical pregnancy was also decreased,
but not significantly (Table 3).
The absence of blastocyst transfer in the age group
>51 years could be explained by the fact that the woman
was often older than 36 years, which in our ART centre
leads to a transfer at day 3.
Sperm quality, paternal age and ICSI results
In ICSI, the fertilization and blastulation rates were signifi-
cantly reduced in the group with sperm concentration
lower than 0.2 M/ml compared with the other sperm con-
centration groups (p <0.0001) (Table 4). Conversely, no
clear link was found between sperm concentration and
proportion of frozen blastocysts. The lower number of
transferred blastocysts in the 0.2 M/ml group could be
explained by the transfer strategy used in our ART
centre. Indeed, in the case of severe oligospermia, the
transfer of two embryos at day 3 is favoured relative to
the transfer at day 5. Like for IVF, the clinical preg-
nancy and early miscarriage rates were not affected by
the sperm concentration.
Surprisingly, the fertilization rate was significantly re-
duced in the group with <32% rapidly progressing
spermatozoa (64.82 vs 67.03% in samples with >32%
rapidly progressing spermatozoa; p <0.013). Conversely,
motility did not affect the blastulation, clinical preg-
nancy and early miscarriage rates (Table 5).
Finally, the pregnancy rate decreased significantly and
the early miscarriage rate tended to be higher in the oldest
paternal age group (>51 years) (woman older than 36 years
of age) (Table 6).
Discussion
The aim of this retrospective study was to assess the effect
of paternal age and of sperm concentration and progres-
sive motility before preparation on the blastulation and
clinical pregnancy rates.
In IVF, progressive motility lower than 32% affected sig-
nificantly the fertilization rate (p <0.0001), but not the
blastulation, clinical pregnancy and early miscarriage rates.
This is in agreement with the work by Chen et al. [12]
Table 1 Effects of sperm concentration in IVF
Sperm concentration (M/ml) Conc < 15 Conc > 15 P value
Mean maternal age (years ± SD) 33.60 ± 4.51 34.36 ± 4.76 0.2235
Number of IVF 52 807
Mean number of inseminated oocytes ± SD 9.54 ± 5.30 9.83 ± 5.46 0.7268
Rate of fertilization (%) 60.08 66.95 0.7381
Mean number of embryos at day 2 ± SD 5.90 ± 4.56 6.84 ± 4.44 0.0702
Mean number of embryos at day 3 ± SD 5.42 ± 3.81 6.14 ± 4.13 0.1911
Mean number of embryos in prolonged culture ± SD 3.69 ± 4.20 3.87 ± 4.02 0.5102
Mean number of obtained blastocysts ± SD 1.94 ± 2.55 2.06 ± 2.59 0.6040
Rate of blastocyst formation (%) 52.6 53.07 0.9107
Mean number of transferred blastocysts ± SD 0.115 ± 0.323 0.104 ± 0.310 0.8808
Mean number of frozen blastocysts ± SD 1.02 ± 1.58 0.990 ± 1.780 0.7155
Rate of useful blastocysts (%) 58.42 53.22 0.0181
Rate of clinical pregnancy (%) 28.89 37.96 0.228
Rate of miscarriage (%) 30.77 21.80 0.3832
Conc concentration, M/ml million per ml, SD standard deviation
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who did not find any significant difference concerning
sperm concentration, total motility, progressive motility
and rapid progressive motility between the clinical preg-
nancy and non-pregnancy groups. Differently from our
study where sperm analysis was performed on fertilization
day, in the study by Chen et al., sperm was analysed in the
6 months before the attempt.
In ICSI, sperm concentration before preparation did
not affect the cycle outcomes (clinical pregnancy or early
spontaneous miscarriage). Similarly, rapid progressive
motility (< or >32%) did not affect the blastocyst forma-
tion, clinical pregnancy and early miscarriage rates. The
effect of sperm concentration and rapid progressive
motility on the fertilization rate with ICSI (Table 5)
could be explained by the bias linked to the association
between asthenozoospermia and oligozoospermia. Borges
et al. [13] reported that sperm concentration before
preparation influences the fertilization rate in ICSI (OR
3.994, p = 0.015), but not the rate of blastocyst formation.
However, in this study, patients were classified only in two
groups (concentration > or <15 M/ml), which did not
allow highlighting the effect of severe oligozoospermia on
the rate of blastocyst formation found in our study
(Table 4).
In our analysis, we did not take into account the per-
centage of normal forms on fertilization day. This bias is,
however, limited because the literature is not unanimous
on the effect of teratozoospermia on the outcome of ART
Table 2 Effects of progressive motility in IVF
Progressive motility (%) <32 >32 P value
Mean maternal age (years ± SD) 34.68 ± 4,17 34.31 ± 4.76 0.8207
Number of IVF 22 836
Mean number of inseminated oocytes ± SD 10.14 ± 7.43 9.81 ± 5.39 0.7195
Fertilization rate (%) 47.98 67.05 <0.0001
Mean number of embryos at day 2 ± SD 5.18 ± 4.47 6.82 ± 4.45 0.0263
Mean number of embryos at day 3 ± SD 4.77 ± 4.14 6.14 ± 4.11 0.0746
Mean number of embryos in prolonged culture ± SD 2.64 ± 3.81 3.90 ± 4.04 0.0972
Mean number of obtained blastocysts ± SD 1.59 ± 2.99 2.06 ± 2.58 0.0792
Rate of blastocyst formation (%) 60.34 52.90 0.2601
Mean number of transferred blastocysts ± SD 0.045 ± 0.213 0.106 ± 0.312 0.6314
Mean number of frozen blastocysts ± SD 0.682 ± 1.550 1.000 ± 1.770 0.25563
Rate of useful blastocysts (%) 45.71 53.65 0.3511
Rate of clinical pregnancy (%) 33.30 37.60 0.7138
Rate of miscarriage (%) 50.00 21.60 0.7155
SD standard deviation
Table 3 Effects of paternal age on IVF
Paternal age (years) 20 < Age < 29 30 < Age < 39 40 < Age < 50 Age > 51 P value
Mean maternal age (years ± SD) 29.39 ± 5.11 34.22 ± 4.18 37.08 ± 3.43 37.00 ± 5.77 <0.0001
Number of IVF 114 524 211 10
Mean number of inseminated oocytes ± SD 10.11 ± 5.72 9.99 ± 5.44 9.31 ± 5.26 7.30 ± 6.17 0.1024
Fertilization rate (%) 64.01 67.66 65.99 42.46 <0.0001
Mean number of embryos at day 2 ± SD 6.76 ± 4.29 7.01 ± 4.58 6.38 ± 4.12 3.40 ± 4.67 0.0104
Mean number of embryos at day 3 ± SD 6.13 ± 3.88 6.31 ± 4.17 5.72 ± 4.02 2.90 ± 4.15 0.0048
Mean number of embryos in prolonged culture ± SD 3.51 ± 3.68 4.09 ± 4.16 3.60 ± 3.86 1.60 ± 3.53 0.0408
Mean number of obtained blastocysts ± SD 1.74 ± 2.35 2.25 ± 2.73 1.78 ± 2.30 0.90 ± 2.02 0.0319
Rate of blastocyst formation (%) 49.50 54.97 49.41 56.25 0.0255
Mean number of transferred blastocysts ± SD 0.053 ± 0.224 0.113 ± 0.322 0.118 ± 0.324 0.000 ± 0.000 0,6987
Mean number of frozen blastocysts ± SD 0.667 ± 1.420 1.040 ± 1.830 1.070 ± 1.780 0.700 ± 1.640 0.3081
Rate of useful blastocysts (%) 41.41 51.10 66.93 77.78 <0.0001
Rate of clinical pregnancies (%) 28.60 38.90 39.70 14.30 0.1151
Rate of miscarriages (%) 17.90 18.60 34.40 NR 0.3504
SD standard deviation, NR not reported (missing data)
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attempts. Zhu et al. [14] suggested that isolated terato-
zoospermia (<4% of normal forms according to the
Kruger’s classification [15]) justifies the use of ICSI versus
IVF to improve the fertilization rate. Conversely,
according to Lockwood et al. [16], teratozoospermia is
not a parameter to be taken into account for the choice
of ART technique and allows even intra-uterine insemina-
tions. These results confirm those reported by Fan et al.
[17]. Many other groups also previously demonstrated the
absence of effect of isolated teratozoospermia on IVF
results [18–21].
In our study, sperm concentration lower than 0.2 M/ml
was the only sperm-related factor that influenced nega-
tively the blastocyst formation rate after ICSI. This is in
agreement with the study by Miller and Smith [22] who
also found a higher blastulation rate in IVF than in ICSI,
which was performed only in the case of reduced sperm
motility or of 4 ≤ normal forms. In the same study,
increasing paternal age influenced the blastocyst forma-
tion rate, independently of the used fertilization technique.
We found a similar effect when paternal age was higher
than 50 years, but only in the IVF subgroup. In our study,
rapid progressive motility did not have any effect on the
blastulation rate (both techniques), differently from what
reported previously [22, 23].
The effect of severe oligozoospermia on the fertilization
and blastulation rates after ICSI could be partially ex-
plained by an elevated DNA fragmentation rate (i.e., DNA
Table 4 Effects of sperm concentration in ICSI
Sperm concentration (M/ml) Conc < 0.2 0.2 < Conc < 5 5 < Conc < 15 Conc > 15 P value
Mean maternal age (years ± SD) 32.97 ± 5.05 31.98 ± 5.11 32.81 ± 5.05 33.94 ± 4.83 0.6257
Number of ICSI 282 373 326 651
Mean number of injected oocytes ± SD 8.04 ± 4.52 8.50 ± 4.80 7.81 ± 4.29 7.28 ± 4.24 0.0007
Fertilization rate (%) 58.29 61.87 65.30 68.95 <0.0001
Mean number of embryos at day 2 ± SD 4.40 ± 3.30 5.04 ± 3.70 4.97 ± 3.56 4.81 ± 3.55 0.1515
Mean number of embryos at day 3 ± SD 4.03 ± 3.39 4.21 ± 3.51 4.25 ± 3.30 4.17 ± 3.33 0.7636
Mean number of embryos in prolonged culture ± SD 2.15 ± 2.93 2.78 ± 3.50 2.77 ± 3.43 2.73 ± 3.23 0.0562
Mean number of obtained blastocysts ± SD 0.84 ± 1.63 1.32 ± 2.15 1.44 ± 2.10 1.36 ± 2.07 0.0014
Rate of blastocyst formation (%) 39.17 47.49 51.88 49.69 <0.0001
Mean number of transferred blastocysts ± SD 0.035 ± 0.185 0.042 ± 0.228 0.092 ± 0.300 0.093 ± 0.307 0.3593
Mean number of frozen blastocysts ± SD 0.344 ± 0.980 0.592 ± 1.230 0.610 ± 1.400 0.516 ± 1.210 0.1113
Rate of useful blastocysts (%) 45.155 48.07 48.93 44.96 0.4562
Rate of clinical pregnancies (%) 35.30 41.30 39.60 37.60 0.4980
Rate of miscarriages (%) 22.70 9.60 14.90 21.00 0.1572
Conc concentration, M/ml million per ml, SD, standard deviation
Table 5 Effects of progressive motility in ICSI
Progressive motility (%) <32 >32 P value
Mean maternal age (years ± SD) 33.02 ± 5.13 33.54 ± 4.90 0.0601
Number of ICSI 852 657
Mean number of injected oocytes ± SD 8.01 ± 4.48 7.42 ± 4.38 0.0041
Fertilization rate (%) 64.82 67.03 0.013
Mean number of embryos at day 2 ± SD 4.97 ± 3.64 4.82 ± 3.49 0.5315
Mean number of embryos at day 3 ± SD 4.26 ± 3.45 4.16 ± 3.32 0.6800
Mean number of embryos in prolonged culture ± SD 2.75 ± 3.35 2.71 ± 3.26 0.8990
Mean number of obtained blastocysts ± SD 1.37 ± 2.09 1.28 ± 2.02 0.5681
Rate of blastocyst formation (%) 49.76 47.47 0.1441
Mean number of transferred blastocysts ± SD 0.083 ± 0.297 0.067 ± 0.256 0.6823
Mean number of frozen blastocysts ± SD 0.548 ± 1.200 0.530 ± 1.270 0.6363
Rate of useful blastocysts (%) 46.14 46.44 0.8923
Rate of clinical pregnancies (%) 39.50 38.60 0.7272
Rate of miscarriages (%) 17.10 15.30 0.6893
SD standard deviation
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strand breaks). Many studies have tried to determine the
effect of DNA fragmentation on the fertilization, preg-
nancy and spontaneous miscarriage rates. At low level,
these breakages are repaired in the oocyte after
fertilization. Beyond a certain level, they cannot be effi-
ciently repaired to allow normal embryo development.
Many studies have observed the absence of links between
the DNA fragmentation index (DFI) and the quality of
embryos generated with ICSI [24–30]. Moreover, accord-
ing to Evenson et al. [31], improving sperm chromatin
structure during ART is not associated with higher
fertilization and embryo quality rates. The absence of cor-
relation between DFI and embryo quality could be par-
tially explained by the fact that better quality spermatozoa
are chosen for ICSI [30]. However, other studies have
highlighted the existence of an association between the
level of sperm DNA fragmentation and degree of embryo
fragmentation after ICSI [32–39]. Guérin et al. [40] never
obtained a successful pregnancy, when sperm DFI was
higher than 45%, whatever the ART technique used.
Larson et al. [41] found that if more than 27% of
spermatozoa show DNA denaturation, no pregnancy
can be obtained after ICSI. For Simon et al. [42], increased
sperm DNA fragmentation is associated with abnormal
protamination and results in lower fertilization rates,
poorer embryo quality and reduced pregnancy rates.
New approaches are needed for sperm selection. A
very interesting study by Muratori et al. [43] provides
the evidence that the density gradient centrifugation
procedure produces an increase in sperm DNA fragmen-
tation in some subjects undergoing IVF/ICSI, who then
show a much lower probability of pregnancy, raising
concerns about the safety of this selection procedure.
Alternative sperm selection strategies are recommended
for those patients.
Unfortunately, we did not record male body mass
index (BMI) in our study. This is obviously a limitation
for our results interpretation as more and more studies
have highlighted to role of BMI of men on fertility
issues. In 2013, Anifandis et al. [44] showed that even if
male BMI did not correlate with sperm parameters, the
groups with the highest BMI had the lowest embryo
quality. Moreover, the combination of BMI and age of
both men and women had a negative effect on preg-
nancy rate. A more recent systematic review with thirty
papers included [45] confirm these results. Men obesity
does not influence conventional sperm parameters but is
associated with reduction of live birth rate per cycle and
an increase of DNA fragmentation.
The effects of paternal age are difficult to interpret
due to the maternal age bias. Indeed, paternal age is
strictly correlated with that of the female partner. Our
univariate analysis did not allow determining the inci-
dence of paternal age «alone» on the different parame-
ters under study. Nevertheless, our results suggest that
from the age of 51 years, paternal age negatively affects
the rates of blastocyst formation (IVF) and of clinical
pregnancy (ICSI). For both techniques, the rate of early
miscarriage was slightly higher (but not significantly) in
the age group >51 years. The pregnancy rate reduction
associated with increasing paternal age has been already
described by Hassan and Killik [46] and De La Rochebro-
chard and Thonneau [47]). Increasing paternal age also
has an effect on the rate of early miscarriages. De La
Rochebrochard et al. [48] reported that in the case of ma-
ternal age over 35 years and paternal age over 40 years,
Table 6 Effects of paternal age in ICSI
Paternal age (years) 2 0 < Age < 29 30 < Age < 39 40 < Age < 50 Age > 51 P value
Mean maternal age (years ± SD) 27.54 ± 4.55 32.69 ± 4.12 36.72 ± 3.95 36.53 ± 4.90 <0.0001
Number of ICSI 226 949 410 47
Mean number of injected oocytes ± SD 8.69 ± 4.27 7.89 ± 4.53 7.15 ± 4.36 7.32 ± 3.82 <0.0001
Fertilization rate (%) 61.05 65.20 64.57 70.35 0.0007
Mean number of embryos at day 2 ± SD 5.11 ± 3.58 4.92 ± 3.60 4.46 ± 3.45 4.74 ± 3.09 0.0400
Mean number of embryos at day 3 ± SD 4.24 ± 3.28 4.27 ± 3.48 3.88 ± 3.18 4.32 ± 3.30 0.3273
Mean number of embryos in prolonged culture ± SD 2.89 ± 3.51 2.73 ± 3.29 2.35 ± 3.20 2.45 ± 2.86 0.0821
Mean number of obtained blastocysts ± SD 1.46 ± 2.39 1.31 ± 2.00 1.10 ± 1.91 1.13 ± 1.94 0.1376
Rate of blastocyst formation (%) 50.38 48.11 46.99 46.09 0.5682
Mean number of transferred blastocysts ± SD 0.044 ± 0.227 0.077 ± 0.282 0.076 ± 0.274 0.064 ± 0.247 0.8895
Mean number of frozen blastocysts ± SD 0.619 ± 1.300 0.544 ± 1.170 0.410 ± 1.250 0.617 ± 1.410 0.0069
Rate of useful blastocysts (%) 45.59 47.27 43.93 60.38 0.1271
Rate of clinical pregnancies (%) 41.50 41.00 32.10 28.20 0.0162
Rate of miscarriages (%) 17.40 14.60 20.70 45.50 0.3510
SD standard deviation
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the risk of early miscarriage is increased. For Kleinhaus
[49], this risk is present from the age of 40 years, also after
adjustment for maternal age (OR 1.6 vs <25 years). Finally,
Slama [50] found that the risk of early miscarriage is
higher starting from the paternal age of 35 years. Finally,
there is probably a cumulative effect of increasing paternal
and maternal age. According to our results, we consider
as threshold ages 37 years for women and 51 for men.
Conclusion
This study shows that some male factors are significantly
associated with ART outcomes. Independently of the
used technique (IVF or ICSI), sperm rapid progressive
motility affect the fertilization rate. In ICSI, oligospermia
affect the fertilization rate and severe oligospermia
(<0.2 M/ml) causes also a reduction of the blastulation
rate. Increasing paternal age (>51 years) negatively influ-
ences the rate of clinical pregnancy when the woman is
older than 37 years. These results allow adjusting the
fertilization and embryo transfer strategies in our ART
centre. For severe oligospermia, it should be better to
propose a transfer at the cleaved embryo stage because
the blastocyst formation rate is significantly reduced.
Finally, different promising research avenues, described
in the recent study by Bounartzi et al. [51], should be
explored, such as the quantification of free sperm DNA
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